Monday, 15 June 2020

Eli Lilly starts late-stage study of arthritis drug in COVID-19 patients

U.S. drugmaker Eli Lilly and Co said on Monday it has started a late-stage trial testing its rheumatoid arthritis drug Olumiant in patients hospitalized with COVID-19.


from Reuters: Health https://ift.tt/3fpJYdP

No comments:

Post a Comment